Lead investor Deerfield Management's Dr. Andrew ElBardissi: This technology has the potential to be the standard of care for a large segment of HF patients that continue to worsen despite the use of approved drugs and devices.
Original Article: Israeli co V-Wave raises $70m for heart failure device trial